Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2052147

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2052147

Vascular Stent Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 199 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

The vascular stent market is witnessing steady expansion driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive surgical procedures, and growing advancements in interventional cardiology technologies. Vascular stents play a crucial role in restoring blood flow in narrowed or blocked arteries, significantly improving patient outcomes and reducing complications associated with cardiovascular disorders. The Vascular Stent Market is expected to reach US$13.6 Bn in 2026 and US$19.8 Bn by 2033, growing at a CAGR of 5.50% during the forecast period.

Market Insights:

The industry is undergoing continuous innovation with the development of advanced drug-eluting and bioresorbable stent technologies aimed at improving long-term clinical outcomes. Increasing preference for minimally invasive procedures among patients and healthcare providers is boosting the adoption of vascular stents globally. Technological advancements in stent design, including enhanced flexibility, thinner struts, and improved biocompatibility, are helping reduce restenosis and thrombosis risks. In addition, rising awareness regarding early diagnosis and treatment of coronary artery disease is supporting market growth across developed and emerging economies.

Drivers:

Key drivers of the vascular stent market include the growing incidence of coronary artery disease, peripheral artery disease, and other cardiovascular conditions associated with sedentary lifestyles, obesity, diabetes, and aging populations. Increasing healthcare expenditure and expanding access to advanced cardiac care facilities are further contributing to market growth. The rising demand for minimally invasive procedures due to shorter hospital stays and faster recovery times is accelerating the use of vascular stents in hospitals and specialty clinics. Furthermore, continuous research and development activities focused on next-generation stent technologies are strengthening industry expansion.

Business Opportunity:

The market presents significant business opportunities for manufacturers investing in bioabsorbable stents, advanced drug-eluting technologies, and personalized cardiovascular treatment solutions. Emerging economies are creating lucrative growth prospects due to improving healthcare infrastructure, growing patient awareness, and increasing investments in cardiac care services. Partnerships between medical device manufacturers and healthcare institutions are expected to accelerate product innovation and commercialization. Additionally, the growing focus on outpatient cardiovascular procedures and ambulatory care settings is likely to expand demand for cost-effective and technologically advanced vascular stents.

Region Analysis:

North America dominates the vascular stent market owing to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and strong adoption of innovative interventional cardiology technologies. Europe follows closely due to increasing geriatric population and growing demand for minimally invasive cardiovascular procedures. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period due to rising healthcare investments, increasing cardiovascular disease burden, and improving access to advanced treatment facilities in countries such as China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as promising markets supported by healthcare modernization initiatives and expanding cardiac care services.

Key Players:

  • Medtronic Plc (Ireland)
  • Abbott Laboratories (US)
  • Boston Scientific Corporation (US)
  • B Braun SE (Germany)
  • Terumo Corporation (Japan)
  • Biotronik SE & Co. KG (Germany)
  • Shanghai Microport Medical (Group) Co., Ltd (China)
  • Meril Life Science Pvt. Ltd (India)
  • Sahajanand Medical Technologies Limited (India)
  • Becton, Dickinson, and Company (US)

Segmentation:

By Type

  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bio absorbable Stents

By Material

  • Metal
  • Polymeric
  • Combination

By End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Specialty Clinics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vascular Stent Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Vascular Stent Market Outlook, 2020 - 2033

  • 3.1. Global Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Drug-Eluting Stents
    • 3.1.2. Bare-Metal Stents
    • 3.1.3. Bio absorbable Stents
  • 3.2. Global Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 3.2.1. Metal
    • 3.2.2. Polymeric
    • 3.2.3. Combination
  • 3.3. Global Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Ambulatory Surgery Centers (ASCs)
    • 3.3.3. Specialty Clinics
  • 3.4. Global Vascular Stent Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Vascular Stent Market Outlook, 2020 - 2033

  • 4.1. North America Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Drug-Eluting Stents
    • 4.1.2. Bare-Metal Stents
    • 4.1.3. Bio absorbable Stents
  • 4.2. North America Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 4.2.1. Metal
    • 4.2.2. Polymeric
    • 4.2.3. Combination
  • 4.3. North America Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgery Centers (ASCs)
    • 4.3.3. Specialty Clinics
  • 4.4. North America Vascular Stent Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Vascular Stent Market Outlook, by Type, 2020-2033
    • 4.4.2. U.S. Vascular Stent Market Outlook, by Material, 2020-2033
    • 4.4.3. U.S. Vascular Stent Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Vascular Stent Market Outlook, by Type, 2020-2033
    • 4.4.5. Canada Vascular Stent Market Outlook, by Material, 2020-2033
    • 4.4.6. Canada Vascular Stent Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Vascular Stent Market Outlook, 2020 - 2033

  • 5.1. Europe Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Drug-Eluting Stents
    • 5.1.2. Bare-Metal Stents
    • 5.1.3. Bio absorbable Stents
  • 5.2. Europe Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 5.2.1. Metal
    • 5.2.2. Polymeric
    • 5.2.3. Combination
  • 5.3. Europe Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Ambulatory Surgery Centers (ASCs)
    • 5.3.3. Specialty Clinics
  • 5.4. Europe Vascular Stent Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.2. Germany Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.3. Germany Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.5. Italy Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.6. Italy Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.7. France Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.8. France Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.9. France Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.11. U.K. Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.12. U.K. Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.14. Spain Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.15. Spain Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.17. Russia Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.18. Russia Vascular Stent Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Vascular Stent Market Outlook, by Type, 2020-2033
    • 5.4.20. Rest of Europe Vascular Stent Market Outlook, by Material, 2020-2033
    • 5.4.21. Rest of Europe Vascular Stent Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Vascular Stent Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Drug-Eluting Stents
    • 6.1.2. Bare-Metal Stents
    • 6.1.3. Bio absorbable Stents
  • 6.2. Asia Pacific Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 6.2.1. Metal
    • 6.2.2. Polymeric
    • 6.2.3. Combination
  • 6.3. Asia Pacific Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgery Centers (ASCs)
    • 6.3.3. Specialty Clinics
  • 6.4. Asia Pacific Vascular Stent Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.2. China Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.3. China Vascular Stent Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.5. Japan Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.6. Japan Vascular Stent Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.8. South Korea Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.9. South Korea Vascular Stent Market Outlook, by End User, 2020-2033
    • 6.4.10. India Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.11. India Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.12. India Vascular Stent Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.14. Southeast Asia Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.15. Southeast Asia Vascular Stent Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Vascular Stent Market Outlook, by Type, 2020-2033
    • 6.4.17. Rest of SAO Vascular Stent Market Outlook, by Material, 2020-2033
    • 6.4.18. Rest of SAO Vascular Stent Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Vascular Stent Market Outlook, 2020 - 2033

  • 7.1. Latin America Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Drug-Eluting Stents
    • 7.1.2. Bare-Metal Stents
    • 7.1.3. Bio absorbable Stents
  • 7.2. Latin America Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 7.2.1. Metal
    • 7.2.2. Polymeric
    • 7.2.3. Combination
  • 7.3. Latin America Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgery Centers (ASCs)
    • 7.3.3. Specialty Clinics
  • 7.4. Latin America Vascular Stent Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Vascular Stent Market Outlook, by Type, 2020-2033
    • 7.4.2. Brazil Vascular Stent Market Outlook, by Material, 2020-2033
    • 7.4.3. Brazil Vascular Stent Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Vascular Stent Market Outlook, by Type, 2020-2033
    • 7.4.5. Mexico Vascular Stent Market Outlook, by Material, 2020-2033
    • 7.4.6. Mexico Vascular Stent Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Vascular Stent Market Outlook, by Type, 2020-2033
    • 7.4.8. Argentina Vascular Stent Market Outlook, by Material, 2020-2033
    • 7.4.9. Argentina Vascular Stent Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Vascular Stent Market Outlook, by Type, 2020-2033
    • 7.4.11. Rest of LATAM Vascular Stent Market Outlook, by Material, 2020-2033
    • 7.4.12. Rest of LATAM Vascular Stent Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Vascular Stent Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Vascular Stent Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Drug-Eluting Stents
    • 8.1.2. Bare-Metal Stents
    • 8.1.3. Bio absorbable Stents
  • 8.2. Middle East & Africa Vascular Stent Market Outlook, by Material, Value (US$ Bn), 2020-2033
    • 8.2.1. Metal
    • 8.2.2. Polymeric
    • 8.2.3. Combination
  • 8.3. Middle East & Africa Vascular Stent Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgery Centers (ASCs)
    • 8.3.3. Specialty Clinics
  • 8.4. Middle East & Africa Vascular Stent Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Vascular Stent Market Outlook, by Type, 2020-2033
    • 8.4.2. GCC Vascular Stent Market Outlook, by Material, 2020-2033
    • 8.4.3. GCC Vascular Stent Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Vascular Stent Market Outlook, by Type, 2020-2033
    • 8.4.5. South Africa Vascular Stent Market Outlook, by Material, 2020-2033
    • 8.4.6. South Africa Vascular Stent Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Vascular Stent Market Outlook, by Type, 2020-2033
    • 8.4.8. Egypt Vascular Stent Market Outlook, by Material, 2020-2033
    • 8.4.9. Egypt Vascular Stent Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Vascular Stent Market Outlook, by Type, 2020-2033
    • 8.4.11. Nigeria Vascular Stent Market Outlook, by Material, 2020-2033
    • 8.4.12. Nigeria Vascular Stent Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Vascular Stent Market Outlook, by Type, 2020-2033
    • 8.4.14. Rest of Middle East Vascular Stent Market Outlook, by Material, 2020-2033
    • 8.4.15. Rest of Middle East Vascular Stent Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Medtronic Plc (Ireland)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Abbott Laboratories (US)
    • 9.4.3. Boston Scientific Corporation (US)
    • 9.4.4. B Braun SE (Germany)
    • 9.4.5. Terumo Corporation (Japan)
    • 9.4.6. Biotronik SE & Co. KG (Germany)
    • 9.4.7. Shanghai Microport Medical (Group) Co., Ltd (China)
    • 9.4.8. Meril Life Science Pvt. Ltd (India)
    • 9.4.9. Sahajanand Medical Technologies Limited (India)
    • 9.4.10. Becton, Dickinson, and Company (US)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!